Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fondaparinux in Acute PE
NCT00981409Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2007
- Primary completion
- Dec 2008
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of fondaparinux in pulmonary embolism (PE), sponsored by GSK. Started Jul 2007; status: completed.
02
Drugs
fondaparinux
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT00981409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00981409.